NSC756093
| Catalog Number | Pack Size | List Price* | Promo Price* | Quantity | |
|---|---|---|---|---|---|
| HY-12929-1MG | 1 mg | 59,00 | 0,00 | Add | |
| HY-12929-5x1MG | 1 mg * 5 | 114,00 | 0,00 | Add | |
| HY-12929-10MG | 10 mg | 177,00 | 109,80 | Add | |
| HY-12929-25MG | 25 mg | 339,00 | 210,20 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Promotion runs until 31.12.2026Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
SU093
NSC756093 (SU093) is a GBP1:PIM1 interaction inhibitor. NSC756093 binds to GBP1-PIM1 with a Kd of 38 nM. NSC756093 suppresses proliferation, reduces migration, induces G1 phase cell-cycle arrest, and increases apoptotic cell death in ovarian cancer cells. NSC756093 reduces cellular proteasomal activity, induces accumulation of ubiquitinated proteins, and restrains tumor progression and lung metastasis in murine ovarian cancer xenograft models. NSC756093 increases sensitivity of prostate cancer cells to Docetaxel (HY-B0011) and sensitizes GBP1-overexpressing ovarian cancer cells to Paclitaxel (HY-B0015) . NSC756093 can be used for the research of prostate cancer and ovarian cancer[1][2][3][4].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer |
| Format | Solubility: DMSO : 62.5 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.58% |
| Molecular Formula | C20H19NO4 |
| Molecular Weight | 337.37 |
| CAS-Number | 1629908-92-4 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
